Verified email-pattern data for Rewire is currently limited. You can still use the company insights and contact sections below.
ReWIRE is set up to equip next-generation scientists with unique skills to develop groundbreaking therapeutic solutions for patients with paralysis. The overall goal is to translate combinatorial SCI therapies from bench to bedside in a timely manner, thereby improving the patients’ quality of life and reducing societal burden. The specific transdisciplinary and translational aspects will fill a gap in the traditional education programs and foster R&D competence in the field of medical products and therapies focused on spinal cord injury. ReWIRE will combine innovative translational neurotechnologies and rehabilitation interventions for the repair and restoration of neurological functions following injury of the spinal cord (SC). The proposed research program will equip next-generation scientists with unique skills to develop disruptive therapeutic solutions for patients with paralysis. Recent technological breakthroughs have triggered a paradigm shift in the conception of therapies aimed to restore function after spinal cord injury (SCI). Novel drug delivery systems and biomaterial bridges have been engineered to reduce secondary injury and scarring, to stimulate and guide regenerating nerve fibres across the lesion site, and to promote functional reconnection with intact tissue. Additionally, neuromodulation therapies can reactivate spinal circuits below a SCI, allowing people with chronic paralysis to regain voluntary control of walking. In conjunction with rehabilitation, neurological recovery was promoted that persisted without neuromodulation, suggesting a rewiring of the SC as demonstrated in preclinical models. To bypass an injury, neuromodulation has been linked to brain signals to re-establish cortical control over spinal circuits by employing electrical nerve stimulation and robotic systems. Advances in robotics are significantly augmenting the impact of neurorehabilitation by inducing new natural “wired” connections.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Forckenbeckstr. 50, Dwi,germany
- Industry
- Medical Equipment Manufacturing
- Keywords
- Biomedical devices, Spinal Cord Injury, Doctoral Network, International Research Network, Combinatorial Therapies, Paralysis, Marie Skłodowska-Curie Doctoral Networks, Science, STEM, Biomedical Science, PhD, Rehabilitation, neurological recovery, educational network, Europe, clinical data platform.
- HQ
- Aachen, NRW
Rewire Questions
ReWIRE's website is https://www.dwi.rwth-aachen.de/en/page/rewire
ReWIRE's LinkedIn profile is https://de.linkedin.com/company/dn-rewire
ReWIRE has
3 employees.
View email and phone details for 3
employees at ReWIRE.
ReWIRE's industry is
Medical Equipment Manufacturing
ReWIRE's categories are Medical Equipment Manufacturing
ReWIRE's founding year is 2023
Top ReWIRE Employees
-
Bianca Yu
n/a
Lausanne, Vaud, Switzerland, Switzerland1stanford.edu -
Maria Justino
Msca (Rewire) Doctoral Student At Cea…
Grenoble, Auvergne-Rhône-Alpes, France, France -
Firman Isma Serdana
Research Focus On Neurotechnology…
Pontedera, Tuscany, Italy, Italy
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.